Barely Significant
← all excerpts

Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy.

Cancer Immunol Immunother · 2025 · PMC11794847 · PMID 39904774

Europe PMCDOI
1
hedged sentence
0.1420
closest p · 2.8× alpha
0.1420
boldest claim

The sentences

not yet significantP = 0.142not close (p > 0.1)
Although the statistical significance is not yet significant, patients with high expression of HEVM tend to have a better prognosis (Fig. 1 C; HR = 0.66, P = 0.142).

also in 225 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.